Biological material Access Process
The Biobanque québécoise de la COVID-19 (BQC19) invites the scientific community to submit their requests for access to the BQC19 biological material and data.
Requests for access biological material and data are accepted throughout the year. The reviews of the requests by the BQC19’s access committee will be done at fixed dates on a quarterly basis.
The next rounds of reviews will be held in August and in November 2021.
The access process has been updated (see here) and the data and material currently available, as well as those to come, are announced on the BQC19 website. The participants recruited to the BQC19 are from two cohorts, hospitalized participants or participants who demonstrated non-hospitalized forms of COVID-19.
The biological material currently available corresponds to different types of samples that were collected from 2,500 participants. Samples include: plasma collected on acid citrate dextrose (ACD) tubes, serum, peripheral blood mononuclear cells (PBMCs), RNA and DNA. A more detailed list is available here.
The BQC19 data correspond to clinical data on more than 2,500 BQC19 participants (having a positive (case) or negative (control) PCR test for SARS-CoV-2). The BQC19 can currently share whole genome coverage by GWAS on some of the participants. The access process will be extended to additional experimental data as they become available.
Note that access to data only is done through a separate process that takes place continuously throughout the year. For access to data only, click here.